113 related articles for article (PubMed ID: 31738322)
21. Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection.
Venkatappa TK; Punnoose R; Katz DJ; Higgins MP; Banaei N; Graviss EA; Belknap RW; Ho CS
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31462550
[TBL] [Abstract][Full Text] [Related]
22. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.
Lee SH; Lew WJ; Kim HJ; Lee HK; Lee YM; Cho CH; Lee EJ; Lee DY; Ryu SW; Oh SY; Kim SO; Shim TS
Respir Med; 2010 Mar; 104(3):448-53. PubMed ID: 19879123
[TBL] [Abstract][Full Text] [Related]
23. Performance of the QuantiFERON
Castellanos ME; Kirimunda S; Martinez L; Quach T; Woldu H; Kakaire R; Handel A; Zalwango S; Kiwanuka N; Whalen CC
Int J Tuberc Lung Dis; 2018 Sep; 22(9):1000-1006. PubMed ID: 30092864
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
25. Role of the QuantiFERON®-TB Gold In-Tube test in the diagnosis of intrathoracic childhood tuberculosis.
Lodha R; Mukherjee A; Saini D; Saini S; Singh V; Singh S; Grewal HM; Kabra SK;
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1383-8. PubMed ID: 24125438
[TBL] [Abstract][Full Text] [Related]
26. Brief Report: Yield of Repeat Tuberculin Skin Testing for People Living With HIV in Brazil.
Chaisson LH; Saraceni V; Cohn S; Cavalcante SC; Chaisson RE; Durovni B; Golub JE
J Acquir Immune Defic Syndr; 2021 Dec; 88(4):329-332. PubMed ID: 34334739
[TBL] [Abstract][Full Text] [Related]
27. Comparison of tuberculin skin test and QuantiFERON®-TB Gold In-Tube for the diagnosis of childhood tuberculosis.
Uzunhan O; Törün SH; Somer A; Salman N; Köksalan K
Pediatr Int; 2015 Oct; 57(5):893-6. PubMed ID: 25903010
[TBL] [Abstract][Full Text] [Related]
28. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis.
Higuchi K; Harada N; Mori T
Respirology; 2008 May; 13(3):468-72. PubMed ID: 18399875
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?
Akyuz F; Cavus B; Iliaz R; Soyer OM; Ormeci A; Evirgen S; Onder S; Koksalan K; Keskin M; Karaca C; Demir K; Gulluoglu M; Cagatay T; Besisik F; Kaymakoglu S
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):777-780. PubMed ID: 30964811
[TBL] [Abstract][Full Text] [Related]
30. Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway.
Pullar ND; Steinum H; Tonby K; Heggelund L; Leiva RA; Ofstad R; Bruun JN; Dyrhol-Riise AM
Int J Tuberc Lung Dis; 2014 Feb; 18(2):180-7. PubMed ID: 24429310
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.
Lempp JM; Zajdowicz MJ; Hankinson AL; Toney SR; Keep LW; Mancuso JD; Mazurek GH
PLoS One; 2017; 12(5):e0177752. PubMed ID: 28545136
[TBL] [Abstract][Full Text] [Related]
32. Use of the QuantiFERON®-TB Gold in Tube test for screening TB contacts and predictive value for active TB.
Yoshiyama T; Harada N; Higuchi K; Saitou M; Kato S
Infect Dis (Lond); 2015 Aug; 47(8):542-9. PubMed ID: 25901728
[TBL] [Abstract][Full Text] [Related]
33. Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.
Zellweger JP; Sotgiu G; Block M; Dore S; Altet N; Blunschi R; Bogyi M; Bothamley G; Bothe C; Codecasa L; Costa P; Dominguez J; Duarte R; Fløe A; Fresard I; García-García JM; Goletti D; Halm P; Hellwig D; Henninger E; Heykes-Uden H; Horn L; Kruczak K; Latorre I; Pache G; Rath H; Ringshausen FC; Ruiz AS; Solovic I; Souza-Galvão ML; Widmer U; Witte P; Lange C;
Am J Respir Crit Care Med; 2015 May; 191(10):1176-84. PubMed ID: 25763458
[TBL] [Abstract][Full Text] [Related]
34. Absence of interferon-gamma release assay conversion following tuberculin skin testing.
Ritz N; Yau C; Connell TG; Tebruegge M; Leslie D; Curtis N
Int J Tuberc Lung Dis; 2011 Jun; 15(6):767-9. PubMed ID: 21575296
[TBL] [Abstract][Full Text] [Related]
35. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
[TBL] [Abstract][Full Text] [Related]
36. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
[TBL] [Abstract][Full Text] [Related]
37. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
[TBL] [Abstract][Full Text] [Related]
38. Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.
Nijhawan AE; Iroh PA; Brown LS; Winetsky D; Porsa E
BMC Infect Dis; 2016 Oct; 16(1):564. PubMed ID: 27733123
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
Diel R; Nienhaus A; Loddenkemper R
Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
[TBL] [Abstract][Full Text] [Related]
40. Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response.
Sauzullo I; Mengoni F; Ermocida A; Massetti AP; D'Agostino C; Russo G; Salotti A; Falciano M; Vullo V; Mastroianni CM
New Microbiol; 2014 Apr; 37(2):153-61. PubMed ID: 24858642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
